Advertisment

Understanding the 2025 Medicare Prescription Payment Plan and Its Impact on Beneficiaries

author-image
Anthony Raphael
New Update
NULL

Understanding the 2025 Medicare Prescription Payment Plan and Its Impact on Beneficiaries

Advertisment

Introduction to the Medicare Prescription Payment Plan

Advertisment

The Medicare Prescription Payment Plan, set to take effect in 2025, is a part of the #InflationReductionAct initiated by President Biden. The primary goal of this plan is to make prescription drugs more affordable for Medicare beneficiaries by reducing their out-of-pocket costs and allowing these costs to be spread throughout the year. This plan is a substantial step towards alleviating the financial burdens associated with healthcare for people with Medicare.

Key Provisions of the Medicare Prescription Payment Plan

As part of the Inflation Reduction Act, the Medicare Prescription Payment Plan will allow people to pay their Medicare Part D out-of-pocket costs over the course of the year starting in 2025. The law includes provisions such as caps on out-of-pocket costs and the cost of insulin. Furthermore, a mandate requires drug companies to pay a rebate to Medicare if they raise prices faster than inflation. This plan complements other provisions aimed at lowering prescription drug and health care costs, such as the expansion of eligibility for the Low Income Subsidy program and capping out of pocket costs for some people enrolled in Medicare Part D.

Advertisment

Proposed Payment Updates for the 2025 Medicare Programs

CMS has proposed payment updates for the 2025 Medicare Advantage and Medicare Part D Prescription programs. These changes are expected to increase Medicare Advantage plan revenues by an average of 3.70%, which equates to a $16 billion increase in overall payments from 2024 to 2025. The proposed rule includes the adoption of a newly defined standard Part D benefit design featuring three phases: annual deductible, initial coverage, and catastrophic coverage. Additionally, the changes entail a lower annual out-of-pocket threshold of $2,000, the sunset of the Coverage Gap Discount Program (CGDP), and the establishment of the Manufacturer Discount Program. The proposed rule also sets adjustments to the liability of enrollees, sponsors, manufacturers, and CMS within the new standard Part D benefit design.

Benefiting Older Americans

Advertisment

Limiting out-of-pocket drug spending will greatly benefit older Americans, enabling them to afford necessary medications. Starting in 2025, Medicare beneficiaries will not have to pay more than $2,000 a year in copays or coinsurance for the prescription drugs their plan covers. Millions of people in Medicare prescription drug plans will benefit from this new protection, making healthcare more accessible and affordable.

Additional Changes and Proposals

Other proposed changes for the Medicare Advantage and Medicare Part D Prescription Drug program for 2025 include an expected 3.7% increase in payments to Medicare Advantage plans, lower drug costs for millions of people on Medicare, and a cap on annual out-of-pocket costs at $2,000 for people with Medicare Part D. The proposed policy changes on Medicare Advantage plan payments relative to 2024 are also outlined, including adjustments to the per capita cost calculations and risk adjustment models. Updates to the 2025 Star Ratings are also proposed, including adjustments for eligible disasters and non-substantive measure specification updates.

Advertisment

Conclusion: An Overview of the Proposed Changes

The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule regarding Contract Year 2025 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit Programs. The proposed changes aim to address concerns about agent and broker compensation incentivizing beneficiaries to enroll in certain MA plans, setting a national fixed compensation amount for agents and brokers, and prohibiting volume-based bonuses for enrollment. The proposed rule also seeks to improve access to behavioral health care services for MA enrollees, increase the percentage of dually eligible MA plan enrollees, and promote access to affordable biosimilar and generic products.

In sum, the Medicare Prescription Payment Plan set to take effect in 2025 represents a significant stride towards making healthcare and prescription drugs more affordable and accessible for Medicare beneficiaries.

Advertisment
Chat with Dr. Medriva !